Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'purotoxin 1'

Search results for: 'purotoxin 1'

Items 21-30 of 37

Page
per page
  1. Remodelin
    B4887 Remodelin
    Target: NAT10
    Summary: NAT10 inhibitor
      ≥36.3 mg/mL
  2. Tofacitinib (CP-690550) Citrate
    A4135 Tofacitinib (CP-690550) Citrate
     2 Citation
    Target: JAK
    Summary: Potent JAK inhibitor
      ≥25.22 mg/mL
  3. Tenovin-6
    A8302 Tenovin-6
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT inhibitor and p53 activator
      ≥22.75 mg/mL
  4. AZD2461
    A4164 AZD2461
    Target: PARP
    Summary: Novel PARP inhibitor
      insoluble in H2O; ≥16.35 mg/mL
  5. CI994 (Tacedinaline)
    A4102 CI994 (Tacedinaline)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥50 mg/mL
  6. SMI-4a
    A4193 SMI-4a
    Target: Pim
    Summary: Potent Pim inhibitor
      insoluble in H2O; ≥13.65 mg/mL
  7. PFI-2
    B4875 PFI-2
     1 Citation
    Target: SETD7
    Summary: SETD7 methyltransferase inhibitor
      ≥50 mg/mL
  8. HPOB
    B4890 HPOB
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor, potent and selective
      ≥31.4 mg/mL
  9. ZM 39923 HCl
    A4151 ZM 39923 HCl
    Target: JAK
    Summary: JAK3 inhibitor,potent and selective
  10. AZD1152
    A3214 AZD1152
     1 Citation
    Target: Aurora Kinases
    Summary: Aurora B kinase inhibitor,highly potent and selective
      insoluble in H2O; insoluble in EtOH; ≥5.88 mg/mL

Items 21-30 of 37

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 2item
  2. Aurora Kinase 4item
  3. HDAC 8item
  4. Histone Acetyltransferases 2item
  5. Histone Demethylases 1 item
  6. Histone Methyltransferase 4item
  7. HIF 2item
  8. JAK 4item
  9. PARP 3item
  10. Pim 2item
  11. Protein Ser/Thr Phosphatases 3item
  12. Sirtuin 2item
Reversibility
  1. Reversible 1 item
Target
  1. Histone Deacetylases (HDACs) 7item
  2. Aurora Kinases 4item
  3. EZH2 1 item
  4. Bromodomains 1 item
  5. FLT3 1 item
  6. MEK 1 item
  7. DOT1L 1 item
  8. Pim 2item
  9. Sir2-like Family Deacetylases (Sirtuins) 2item
  10. PP1 1 item
  11. PP2A 1 item
  12. Src 1 item
  13. Hypoxia Inducible Factors (HIFs) 1 item
  14. JAK 4item
  15. p300 1 item
  16. TNKS 1 item
  17. Topoisomerases 1 item
  18. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  19. PARP 2item
  20. phosphatases 1 item
  21. NAT10 1 item
  22. SETD7 1 item
  23. Histone Demethylases 1 item
  24. Protein Arginine Methyltransferases 1 item
  25. PP4 1 item
  26. c-RET 1 item
  27. Protein polybromo-1 1 item
  28. SMARCA4 1 item
  29. SMARCA2 1 item
  30. Lck 1 item
Reported Experiments
  1. Animal Experiments 28item
  2. Cell Experiments 20item
Related Disease
  1. Acute Myeloid Leukemia 2item
  2. Breast Cancer 5item
  3. Cancer 22item
  4. Cervical Cancer 1 item
  5. Colon Cancer 2item
  6. Colon Carcinoma 1 item
  7. Colorectal Cancer 1 item
  8. Diabetes 1 item
  9. Epilepsy 1 item
  10. Glioma 1 item
  11. Hepatic Cancer 1 item
  12. Hepatocellular Carcinoma 1 item
  13. Inflammatory Diseases 1 item
  14. Leukemia 2item
  15. Lung Cancer 1 item
  16. Lymphoma 2item
  17. Melanoma 1 item
  18. Mixed Lineage Leukemia 1 item
  19. Multiple Myeloma 2item
  20. Myelofibrosis 1 item
  21. Non-small Cell Lung Cancer 2item
  22. Ovarian Cancer 3item
  23. Pancreatic Cancer 2item
  24. Prostate Cancer 5item
  25. Renal Cell Carcinoma 1 item
  26. Rheumatoid Arthritis 1 item